FDA-approved GLP-1/GIP medications for weight loss and type 2 diabetes, including Ozempic, Wegovy, Zepbound, and Mounjaro, may also be eligible for coverage
Quality risk from two grey-market vials
Well assess your situation, determine whether BPC-157 is appropriate, and build a protocol at no cost to you
This metabolic roadblock explains why patients with ME/CFS and Long COVID experience such profound, unyielding fatigue
Individuals often experience a general improvement in their overall wellness, which can contribute to better weight control
The bigger concern is maintaining adequate nutrition and milk supply